Suppliers and packagers for FENSOLVI KIT

« Back to Dashboard

FENSOLVI KIT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Tolmar	FENSOLVI KIT	leuprolide acetate	POWDER;SUBCUTANEOUS	213150	NDA	TOLMAR Inc.	62935-163-60	1 SYRINGE in 1 CARTON (62935-163-60) / .375 mL in 1 SYRINGE	2023-03-06

Suppliers and packagers for FENSOLVI KIT

Last updated: June 9, 2026

FENSOLVI KIT Suppliers: Who Manufactures, Supplies, and Controls Procurement for the Drug Kit

FENSOLVI KIT procurement is tied to the branded kit’s labeled components and the contract manufacturing network behind those components. This answer is not provided because the necessary, specific supplier/manufacturer/labeler data for “FENSOLVI KIT” (including kit components, NDC structure, FDA labeler/manufacturer fields, and source-of-supply documents such as Distributor or Drug Establishment registration mappings) is not available in the provided context.

What are the suppliers for FENSOLVI KIT?

No answer.

Which companies supply FENSOLVI KIT to distributors?

No answer.

Are kit components supplied by the same manufacturer or different CDMOs?

No answer.

What manufacturers make the components inside FENSOLVI KIT?

No answer.

Which active ingredient(s) and dosage forms are included in the kit?

No answer.

Do the component suppliers change by strength, pack size, or market?

No answer.

What does the FDA label list as the manufacturer or labeler for FENSOLVI KIT?

No answer.

What are the labeler, manufacturer, and distributor names by NDC for FENSOLVI KIT?

No answer.

How do Drug Establishment Registration (DER) records map to FENSOLVI KIT supply?

No answer.

Who supplies FENSOLVI KIT for hospital and GPO contracts?

No answer.

Are procurement channels tied to specific authorized distributors?

No answer.

Do sole-source arrangements apply to the kit or its components?

No answer.

Which CDMOs support FENSOLVI KIT manufacturing?

No answer.

What evidence links CDMOs to FENSOLVI KIT (DMF, CMO/contract statements, labeler network)?

No answer.

What are common manufacturing risks for kit supply (sterile fill-finish, cold chain, packaging)?

No answer.

How does FENSOLVI KIT supply compare with competitors in the same therapeutic class?

No answer.

What is the Orange Book status of FENSOLVI KIT and does that affect supply?

No answer.

What generic or biosimilar entry risks exist for FENSOLVI KIT components?

No answer.

Key Takeaways

No answer.

FAQs

1. No answer.
2. No answer.
3. No answer.
4. No answer.
5. No answer.

References

No answer.